Highlights of Focus Meeting 6: Shaping the Future of Breast Cancer Care with Molecular Imaging

Breast cancer remains the most frequently diagnosed cancer and the leading cause of cancer-related death in women worldwide. Despite significant advancements in imaging and treatment, clinical practice remains heterogeneous across institutions and disciplines. Molecular imaging has a pivotal role in breast cancer care, from diagnosis to recurrence assessment. To address these discrepancies and define the future direction of imaging in breast cancer, the European Association of Nuclear Medicine (EANM) devoted its 6th Focus Meeting to this topic, under the following motto “Shaping the Future of Breast Cancer Care with Molecular Imaging”.

The aims of this project were:

• To define the role of imaging in breast cancer, particularly the utility of nuclear medicine techniques in different clinical settings (including initial systemic staging, assessment of response to therapy, and detection of recurrence). 
• To reach a multidisciplinary consensus on the current state of the art in nuclear medicine imaging in breast cancer.
• To generate expert recommendations on how best to guide professionals in their clinical decisions, beyond the existing guidelines. 
• To identify knowledge gaps and topics with lack of scientific evidence for potential future studies.

The recordings in this course are sponsored by Novartis.